Arvinas (ARVN) Receivables (2017 - 2026)
Arvinas' (ARVN) quarterly Receivables came in at $7.8 million in Q1 2026, down 37.6% year-on-year from $12.5 million in Q1 2025, and up 7900.0% quarter-over-quarter from -$100000.0 in Q4 2025.
Arvinas (ARVN) Receivables (2017 - 2026) Analysis & Trends
Arvinas' Receivables history runs 10 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- On a quarterly basis, Receivables fell 37.6% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $7.8 million, a 37.6% decrease from a year earlier, with the FY2025 full-year figure at $8.9 million, down 43.67% from the prior year.
- Receivables rose to $7.8 million in Q1 2026 per ARVN's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Receivables topped out at $26.8 million in Q3 2025 and bottomed at -$100000.0 in Q4 2025.
- The 5-year median for Receivables is $14.8 million (2023), against an average of $14.0 million.
- Across the five-year window, Receivables surged 436.36% in 2023 and tumbled 101.61% in 2025, its largest moves.
- Year by year, Receivables stood at $2.2 million in 2022, then jumped by 436.36% to $11.8 million in 2023, then tumbled by 47.46% to $6.2 million in 2024, then tumbled by 101.61% to -$100000.0 in 2025, then surged by 7900.0% to $7.8 million in 2026.
- Per Business Quant, the three latest ARVN Receivables figures stand at $7.8 million (Q1 2026), -$100000.0 (Q4 2025), and $26.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 7.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.80 Mn |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 14.70 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 16.30 Mn |
| Jun 30, 2024 | 20.70 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 20.60 Mn |
| Jun 30, 2023 | 13.90 Mn |
| Mar 31, 2023 | 14.80 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 17.00 Mn |
| Jun 30, 2022 | 18.40 Mn |
| Mar 31, 2022 | 18.80 Mn |
| Dec 31, 2021 | 19.00 Mn |
| Sep 30, 2021 | 19.56 Mn |
| Jun 30, 2021 | 7.42 Mn |